Spexis AG (SPEXZ.XC)
Cboe UK - Cboe UK Real-time price. Currency in CHF
Add to watchlist
At close: 08:09AM BST
| Previous close | 0.0696 |
| Open | 0.0696 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 0.0696 - 0.0696 |
| 52-week range | 0.0370 - 11.1000 |
| Volume | |
| Avg. volume | 434 |
| Market cap | 4.709M |
| Beta (5Y monthly) | 0.02 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.3700 |
| Earnings date | 05 May 2024 - 09 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GlobeNewswireSpexis Announces Changes to the Executive Committee
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on macrocycle therapeutics for rare diseases and oncology, today announced that Hernan Levett, currently Chief Financial Officer, has decided to pursue a new career opportunity outside the company. He will continue to support the company as a strategic advisor on financial transactions and will depart the company effective
© 2024 Yahoo. All rights reserved.